Dehua Huang

USPTO Granted Patents = 45 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 14 (Patent Applications = 16)

Average Co-Inventor Count = 7.6

ph-index = 10

Forward Citations = 374(Granted Patents)

Company Filing History:

15 out of 169

Signal Pharmaceuticals, Inc.

Merck Sharp + Dohme Corp.

Bristol-myers Squibb Compnay

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

45 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12404239 - Modulators of BCL6 as ligand directed degraders (2025-09-02),

2. 12227490 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2025-02-18),

3. 12103920 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2024-10-01),

4. 11945804 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith (2024-04-02),

5. 11739075 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2023-08-29),

6. 11634407 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2023-04-25),

7. 11590139 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2023-02-28),

8. 11560371 - Cereblon binding compounds, compositions thereof, and methods of treatment therewith (2023-01-24),

9. 11358952 - Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith (2022-06-14),

10. 10940152 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2021-03-09),

11. 10646493 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2020-05-12),

12. 10398700 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2019-09-03),

13. 10149849 - Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith (2018-12-11),

14. 9795607 - Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith (2017-10-24),

15. 9783505 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith (2017-10-10),

Title: The Innovative Journey of Dehua Huang

Introduction

Dehua Huang, based in San Diego, CA, has made significant contributions to the field of pharmaceutical sciences with a remarkable total of 44 patents to his name. His innovative work primarily focuses on the development of compounds that have potential implications in treating various diseases, particularly those mediated by androgen receptors.

Latest Patents

Among his latest patents are groundbreaking compounds known as Cereblon binding compounds. These piperidine dione compounds come with a detailed structure that underscores their therapeutic potential. Huang's patents also outline methods for treating or preventing diseases associated with androgen receptors using these innovative compounds, indicating a promising direction for future medical treatments.

Career Highlights

Throughout his career, Dehua Huang has been associated with notable companies such as Signal Pharmaceuticals and Allergan Sales, Inc. His work in these organizations has played a pivotal role in advancing the field of pharmaceutical innovations. Huang's research and resulting patents reflect his dedication to developing effective therapeutic solutions that address critical health concerns.

Collaborations

Dehua Huang's journey is marked by collaborations with talented individuals in the industry, including Joshua Hansen and Jayasree Vasudevan. These partnerships have undoubtedly contributed to the success of his projects and enhanced the development of new therapeutic compounds.

Conclusion

Dehua Huang stands as a prominent figure in the realm of pharmaceutical innovations, demonstrating exceptional creativity and dedication through his 44 patents. His latest work with Cereblon binding compounds reaffirms the important role inventors play in shaping the future of medicine and science, and his contributions continue to pave the way for breakthroughs that can lead to better treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.